[HTML][HTML] Thrombotic risk in patients with COVID-19
E Pancaldi, G Pascariello, G Cimino… - Reviews in …, 2021 - imrpress.com
Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-
19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical …
19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical …
Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: A systematic review and meta-analysis
Background: D-dimer, a marker of ongoing procoagulant activity, has been widely used for
the diagnosis of venous thromboembolism (VTE). The prognostic significance of D-dimer in …
the diagnosis of venous thromboembolism (VTE). The prognostic significance of D-dimer in …
Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients
The outbreak of COVID-19 has affected billions of people worldwide. The clinical spectrum
of COVID-19 ranges from asymptomatic infection or mild disease to severe pneumonia …
of COVID-19 ranges from asymptomatic infection or mild disease to severe pneumonia …
Current opinion on the use of direct oral anticoagulants for the prophylaxis of venous thromboembolism among medical inpatients
Venous thromboembolism (VTE) is a known cause of morbidity and mortality, especially
among acutely ill medical patients. Although VTE prophylaxis is part of post-discharge …
among acutely ill medical patients. Although VTE prophylaxis is part of post-discharge …
[PDF][PDF] ANTICOAGULANTES ORALES DE ACCIÓN DIRECTA EN LA ENFERMEDAD TROMBOEMBÓLICA VENOSA
FL Sánchez - capitulodeflebologia.org
El descubrimiento de la heparina no fraccionada (HNF) y de las antivitaminas K (AVK)
revolucionaron, en su momento, la prevención y tratamiento de la enfermedad …
revolucionaron, en su momento, la prevención y tratamiento de la enfermedad …